Azentio appoints Harikrishnan Venkataramanan as President – ERP to spearhead next phase of innovation and growth
SINGAPORE, July 3, 2025 /PRNewswire/ — Azentio Software (“Azentio”), a leading technology enabler in the banking, financial services, insurance... Read more.
Novotech Earns Frost & Sullivan’s 2025 Global Company of the Year Recognition for Excellence in Biotech Clinical Research Services
Recognized for its biotech-first focus, innovation in clinical trial delivery, and best-in-class client experience, Novotech sets the global standard in contract... Read more.
Fujitsu to develop ETF trading platform based on TSE’s CONNEQTOR and provide it to Australian Securities Exchange
TOKYO, July 2, 2025 /PRNewswire/ — The Australian Securities Exchange (ASX), the Tokyo Stock Exchange, Inc. (TSE), and Fujitsu Limited on June 2, 2025 signed... Read more.
World-Leading Breakthrough! Risen Energy’s HJT Modules Hit Average 740Wp Mass Production with Record 26.61% Cell Efficiency
NINGBO, China, July 2, 2025 /PRNewswire/ — A milestone in global heterojunction (HJT) photovoltaic technology! Risen Energy Co., Ltd. (Stock Code: 300118)... Read more.
Synopsys Issues Statement in Connection to the Lifting of Recent U.S. Export Restrictions Related to China
SUNNYVALE, Calif., July 2, 2025 /PRNewswire/ — Today, Synopsys, Inc. (Nasdaq: SNPS) issued the below statement in connection with the lifting of recent U.S.... Read more.
MiniTool Released Video Converter 4.3 with New Features
VANCOUVER, BC, July 2, 2025 /PRNewswire/ — MiniTool Software Limited has released a new version of its video conversion tool – MiniTool Video Converter... Read more.
CHAI AI: Total Funding Over $55M
PALO ALTO, Calif., July 2, 2025 /PRNewswire/ — In 2025, CHAI AI secured additional rounds of funding, bringing its total investment to date to over $55M.... Read more.
Lore Link is Here to Help Organize Your Game
INDIANAPOLIS and DENVER, July 2, 2025 /PRNewswire/ — After 4 years in development, Lore Link is now publicly available as an online management tool for tabletop... Read more.
Dizal’s ZEGFROVY® (sunvozertinib) Receives FDA Accelerated Approval as the Only Targeted Oral Treatment for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
ZEGFROVY is the only approved targeted oral treatment for NSCLC with EGFR exon20ins Approval follows the U.S. FDA’s Priority Review and is supported... Read more.
Blokees Becomes Exclusive Strategic Partner of “Journey of Light: A Glimpse into Ultraman’s 60th Anniversary” Exhibition
SHANGHAI, July 2, 2025 /PRNewswire/ — On July 2nd, the much-anticipated exhibition “Journey of Light: A Glimpse into Ultraman’s 60th Anniversary”... Read more.